Gao, Z.; Xu, M.; Liu, C.; Gong, K.; Yu, X.; Lu, K.; Zhu, J.; Guan, H.; Zhu, Q.
Structural Modification and Optimisation of Hyperoside Oriented to Inhibit TGF-β-Induced EMT Activity in Alveolar Epithelial Cells. Pharmaceuticals 2024, 17, 584.
https://doi.org/10.3390/ph17050584
AMA Style
Gao Z, Xu M, Liu C, Gong K, Yu X, Lu K, Zhu J, Guan H, Zhu Q.
Structural Modification and Optimisation of Hyperoside Oriented to Inhibit TGF-β-Induced EMT Activity in Alveolar Epithelial Cells. Pharmaceuticals. 2024; 17(5):584.
https://doi.org/10.3390/ph17050584
Chicago/Turabian Style
Gao, Ziye, Mengzhen Xu, Chuanguo Liu, Kai Gong, Xin Yu, Kaihui Lu, Jiang Zhu, Haixing Guan, and Qingjun Zhu.
2024. "Structural Modification and Optimisation of Hyperoside Oriented to Inhibit TGF-β-Induced EMT Activity in Alveolar Epithelial Cells" Pharmaceuticals 17, no. 5: 584.
https://doi.org/10.3390/ph17050584
APA Style
Gao, Z., Xu, M., Liu, C., Gong, K., Yu, X., Lu, K., Zhu, J., Guan, H., & Zhu, Q.
(2024). Structural Modification and Optimisation of Hyperoside Oriented to Inhibit TGF-β-Induced EMT Activity in Alveolar Epithelial Cells. Pharmaceuticals, 17(5), 584.
https://doi.org/10.3390/ph17050584